Pharmacokinetic study of ceftazidime in bone and serum of patients undergoing hip and knee arthroplasty

J Antimicrob Chemother. 1985 Nov;16(5):637-42. doi: 10.1093/jac/16.5.637.

Abstract

Twenty-eight patients undergoing hip arthroplasty and 15 undergoing knee arthroplasty, received chemoprophylaxis with ceftazidime 1.0 g administered intravenously at the time of induction of anaesthesia, followed by two doses of 500 mg given intramuscularly 6 and 12 h later. The mean bone concentration in hip arthroplasty showed a general rise towards a maximum of approximately 20 mg/kg when the exposure time (interval between antibiotic injection and removal of bone sample) was 35-40 min, with values ranging from 4.4 to 21.2 mg/kg (mean 14.4 mg/kg). The patients undergoing knee arthroplasty present a complicated pharmacokinetic problem, as the use of a tourniquet limits the exposure time. Bone concentrations of ceftazidime were highest at sampling times greater than 20 min in these patients (mean level of 15.9 mg/kg for femoral bone and 13.1 mg/kg for tibial bone).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Bone and Bones / metabolism*
  • Ceftazidime / blood
  • Ceftazidime / metabolism*
  • Ceftazidime / therapeutic use*
  • Female
  • Hip Prosthesis
  • Humans
  • Kinetics
  • Knee Prosthesis
  • Male
  • Middle Aged
  • Premedication*

Substances

  • Ceftazidime